| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015978304 |
| P356 | DOI | 10.1186/2110-5820-2-19 |
| P932 | PMC publication ID | 3488539 |
| P698 | PubMed publication ID | 22709377 |
| P5875 | ResearchGate publication ID | 227341106 |
| P2093 | author name string | Jean-Charles Preiser | |
| Isabelle De Loecker | |||
| P2860 | cites work | Continuation of Statin Therapy in Patients with Presumed Infection | Q59523754 |
| Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect | Q59531972 | ||
| Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia | Q60484520 | ||
| Impact of Previous Statin and Angiotensin II Receptor Blocker Use on Mortality in Patients Hospitalized with Sepsis | Q60484529 | ||
| Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients? | Q60547640 | ||
| Statin therapy prior to ICU admission: protection against infection or a severity marker? | Q64135581 | ||
| Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction | Q72146881 | ||
| Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment | Q73536075 | ||
| Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis | Q74181851 | ||
| Long-term mortality and medical care charges in patients with severe sepsis | Q79075244 | ||
| The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases | Q79495597 | ||
| Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage | Q80108389 | ||
| Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins | Q80140729 | ||
| Statins do not improve short-term survival in an oriental population with sepsis | Q80418456 | ||
| Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage | Q80997584 | ||
| Septic shock | Q81245367 | ||
| Statin therapy is associated with fewer deaths in patients with bacteraemia | Q81470480 | ||
| Statins in the management of aneurysmal subarachnoid hemorrhage--not (yet) a standard of care | Q83270550 | ||
| Meta-analysis of statins for aneurysmal subarachnoid hemorrhage falls short | Q83270556 | ||
| Oxidative stress | Q83388224 | ||
| Comment on "Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury" | Q83826745 | ||
| Calcium antagonists for aneurysmal subarachnoid haemorrhage | Q24244167 | ||
| The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. | Q24811721 | ||
| Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain | Q27619685 | ||
| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
| SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage | Q28211026 | ||
| Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
| Effect of statin treatment on short term mortality after pneumonia episode: cohort study | Q28741391 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome | Q30320030 | ||
| The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells | Q30320333 | ||
| Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. | Q30320421 | ||
| Tidal volume reduction in patients with acute lung injury when plateau pressures are not high | Q30489181 | ||
| Cellular antioxidant effects of atorvastatin in vitro and in vivo | Q30809431 | ||
| Why immunomodulatory therapies have not worked in sepsis | Q33693724 | ||
| Preadmission statin use and one-year mortality among patients in intensive care - a cohort study | Q33919029 | ||
| Normal responses to injury prevent systemic inflammation and can be immunosuppressive | Q34141225 | ||
| Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage | Q34271800 | ||
| The effect of statins on mortality in patients with bacteremia | Q34374856 | ||
| Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors | Q34432988 | ||
| Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats | Q34545086 | ||
| The safety of statins in clinical practice | Q34636135 | ||
| Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome | Q35007498 | ||
| Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update | Q35010436 | ||
| Understanding the potential role of statins in pneumonia and sepsis | Q35116076 | ||
| Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study | Q35128843 | ||
| Current overview of statin-induced myopathy | Q35684789 | ||
| Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review | Q36078168 | ||
| Recently published papers: Sepsis, glucose control and patient-doctor relationships | Q36641996 | ||
| Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management | Q36642058 | ||
| Immunostimulation is a rational therapeutic strategy in sepsis | Q36767892 | ||
| A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage | Q46460439 | ||
| Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes | Q46463155 | ||
| Statin treatment after onset of sepsis in a murine model improves survival | Q46584997 | ||
| Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial | Q46622603 | ||
| Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial | Q46624720 | ||
| Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. | Q46916581 | ||
| Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial | Q46977957 | ||
| Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. | Q47614282 | ||
| Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage | Q48864563 | ||
| Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. | Q50738804 | ||
| Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. | Q51294957 | ||
| Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus. | Q51484046 | ||
| Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. | Q51568511 | ||
| Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. | Q51864833 | ||
| Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. | Q53244439 | ||
| Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. | Q53662097 | ||
| Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study | Q57021865 | ||
| Statins, vitamin D, and severe sepsis | Q57200523 | ||
| Statin use and mortality within 180 days after bacteremia: A population-based cohort study* | Q57300690 | ||
| A Randomized Clinical Trial of Hydroxymethylglutaryl– Coenzyme A Reductase Inhibition for Acute Lung Injury (The HARP Study) | Q57913605 | ||
| Statins and sepsis: multiple modifications at multiple levels. | Q36797719 | ||
| Role of statins in cerebral vasospasm | Q37154638 | ||
| Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis | Q37198654 | ||
| Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers | Q37225099 | ||
| Statin use and risk of community acquired pneumonia in older people: population based case-control study | Q37229844 | ||
| Statin adherence and risk of accidents: a cautionary tale. | Q37347962 | ||
| Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study | Q37387209 | ||
| Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy | Q37607923 | ||
| Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis | Q37634417 | ||
| The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis | Q37736067 | ||
| Clinical practice. Vitamin D insufficiency | Q37830043 | ||
| Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. | Q37901715 | ||
| Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome | Q38407730 | ||
| Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury | Q38521023 | ||
| Statin therapy is associated with decreased mortality in patients with infection | Q39877436 | ||
| Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. | Q40453111 | ||
| A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. | Q42604349 | ||
| Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER? | Q43014569 | ||
| Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site | Q43625666 | ||
| Withdrawal of statins increases event rates in patients with acute coronary syndromes | Q43933090 | ||
| Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction | Q44138516 | ||
| Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin | Q44179197 | ||
| Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome | Q44184903 | ||
| Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis | Q44191718 | ||
| Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis | Q44277349 | ||
| Statins and the risk of pneumonia: a population-based, nested case-control study | Q44356684 | ||
| Statin effects on cholesterol micro-domains in brain plasma membranes | Q44356716 | ||
| Reduction in mortality associated with statin therapy in patients with severe sepsis | Q44463455 | ||
| HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages | Q44490081 | ||
| Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion | Q44556166 | ||
| Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation | Q44576675 | ||
| Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. | Q44738348 | ||
| HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis | Q44880979 | ||
| Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. | Q45037051 | ||
| A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. | Q45183033 | ||
| Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients | Q45240501 | ||
| Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice | Q45735385 | ||
| The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort | Q45894119 | ||
| Statins and vitamin D : editorial to: "increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?" by Bunyamin Yavuz et al. | Q45925295 | ||
| Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. | Q46003090 | ||
| Statins may not protect against vasospasm in subarachnoid haemorrhage. | Q46115414 | ||
| The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial | Q46127227 | ||
| Prior statin use is associated with improved outcomes in community-acquired pneumonia | Q46292549 | ||
| Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression | Q46433219 | ||
| A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality | Q46437410 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 19 | |
| P577 | publication date | 2012-06-18 | |
| P1433 | published in | Annals of Intensive Care | Q18712109 |
| P1476 | title | Statins in the critically ill | |
| P478 | volume | 2 |
| Q64882879 | A possible association between statin use and improved Clostridioides difficile infection mortality in veterans. |
| Q38285554 | Acute respiratory distress syndrome on the intensive care unit |
| Q43568688 | Combined administration of RG7652, a recombinant human monoclonal antibody against PCSK9, and atorvastatin does not result in reduction of immune function |
| Q41338177 | Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis |
| Q38921506 | Effect of Statins on the Mortality of Bacteremic Patients: A Systematic Review and Meta-analysis of Clinical Trials |
| Q58584684 | Improved survival with continuation of statins in bacteremic patients |
| Q64906632 | Lipid profile and statin use in critical care setting: implications for kidney outcome. |
| Q52138888 | Neurologic Complications in the Intensive Care Unit. |
| Q34413797 | New treatments for influenza |
| Q38245046 | Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs |
| Q41975149 | Pharmacological interventions in acute respiratory distress syndrome |
| Q35230483 | Prescribing Patterns of Drugs in Acute Respiratory Distress Syndrome (ARDS): An Observational Study |
| Q35603020 | Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin. |
| Q90732855 | Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis |
| Q93046928 | Statin use and Vital Organ Failure in Patients With Asthma-Chronic Obstructive Pulmonary Disease Overlap: A Time-Dependent Population-Based Study |
| Q37265029 | Systematic review of statins in sepsis: There is no evidence of dose response. |
Search more.